Vaccines against gonorrhea: current status and future challenges.
about
Proteomics of Neisseria gonorrhoeae: the treasure hunt for countermeasures against an old diseaseGonorrhea - an evolving disease of the new millennium.Neisseria gonorrhoeae Evades Calprotectin-Mediated Nutritional Immunity and Survives Neutrophil Extracellular Traps by Production of TdfH.A thermonuclease of Neisseria gonorrhoeae enhances bacterial escape from killing by neutrophil extracellular trapsPhase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study proThinking globally, acting locally: harnessing the immune system to deal with recalcitrant pathogens.Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.The potential impact of vaccination on the prevalence of gonorrhea.Improving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling.Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae.Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.Future prospects for new vaccines against sexually transmitted infections.Peptide Inhibitors Targeting the Neisseria gonorrhoeae Pivotal Anaerobic Respiration Factor AniA.Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model.Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccine.Does the Cervicovaginal Microbiome Facilitate Transmission of Neisseria gonorrhoeae From Women to Men? Implications for Understanding Transmission of Gonorrhea and Advancing Vaccine Development.Intravaginal Administration of Interleukin 12 during Genital Gonococcal Infection in Mice Induces Immunity to Heterologous Strains of Neisseria gonorrhoeae.A Natural Mouse Model for Neisseria Colonization.The role of vaccines in preventing bacterial antimicrobial resistance.Structure of the Recombinant Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against GonococciPhage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidatesNovel Whole-Cell Inactivated Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization
P2860
Q28083737-507AC424-5B58-4596-80ED-C27A414E0EDBQ30235031-5A93191E-7EB0-4D71-9156-B4DA2834E080Q30276223-A82AB350-9B58-4B21-91D2-39C9C94018F8Q30300918-7BE4AB02-0E83-4048-AC6B-5918A03E764EQ30352495-D263E8ED-7440-47F8-84EF-616C7A8E5F78Q33851095-89CCD148-DEB1-4D17-ABAE-C0D4DB976BF7Q35620188-9B8816CA-D0B5-4EFE-BD5B-ECD92960290CQ36049026-81A71A87-487F-4111-956C-A68DC0F17183Q36551134-F4D8EE41-BED2-4C46-8CAF-93E217294B97Q36597767-BF8AB3D5-2D17-4960-9E29-4956427F2B90Q36650971-FDC1545F-ED4C-4BD8-98DE-A08261B08651Q37076884-4D97A462-178B-48F5-83EF-DA316AB468D7Q37120976-0090281A-6BD4-4120-932D-BD1F7BAA5AA1Q37611972-929F688C-E399-4DF1-A228-92EC5671A1A4Q37665012-6E424B3A-23E8-4C82-B78D-3101A049D701Q40184241-38C3D9C9-753A-417F-BC82-9B8AF117CDADQ40303647-A9013DEF-6641-41DA-8A79-90468568DAC8Q42328587-D2FD11D6-B1A0-42B5-884D-B0724AA11EAFQ47139413-D4B81A56-CB36-4525-B58F-CF983047EAFDQ49880282-C082CE3C-1D90-4482-A9B7-1B9DB29EDBF9Q50026697-1729888A-9029-4386-BF0D-41C9D1AC1B74Q50120750-E4FE6FEC-BD1C-484B-A954-738B50B5056AQ57285397-226A94B3-5B1A-47B8-A285-6B2FFF75F45CQ58715493-04135428-82A2-4D0B-BE41-2143F97FA05FQ58764305-C848864C-4C76-47B3-B962-9F1E1E3EAF02
P2860
Vaccines against gonorrhea: current status and future challenges.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Vaccines against gonorrhea: current status and future challenges.
@ast
Vaccines against gonorrhea: current status and future challenges.
@en
Vaccines against gonorrhea: current status and future challenges.
@nl
type
label
Vaccines against gonorrhea: current status and future challenges.
@ast
Vaccines against gonorrhea: current status and future challenges.
@en
Vaccines against gonorrhea: current status and future challenges.
@nl
prefLabel
Vaccines against gonorrhea: current status and future challenges.
@ast
Vaccines against gonorrhea: current status and future challenges.
@en
Vaccines against gonorrhea: current status and future challenges.
@nl
P2860
P1433
P1476
Vaccines against gonorrhea: current status and future challenges
@en
P2093
Ann E Jerse
Margaret C Bash
P2860
P304
P356
10.1016/J.VACCINE.2013.08.067
P407
P577
2013-09-06T00:00:00Z